Navigation Links
Appistry Chief Scientific Officer to Speak at Inaugural Conference on Delivering Genome-Enabled Diagnostics in the Clinic
Date:9/23/2013

St. Louis, MO (PRWEB) September 23, 2013

Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine and the authorized distributor of select genetic analysis tools from the Broad Institute, today announced its chief scientific officer, Dr. Richard Mazzarella, will deliver a presentation titled “Clinical Best Practices for Cancer Genetic Analysis Pipelines,” at Cambridge HealthTech Institute’s inaugural Clinical Genomics for Cancer Diagnostics Conference in Boston Sept. 23-24 at the Seaport Hotel. In his presentation, which will kick off the “Data Interpretation” conference track on Sept. 24, Mazzarella will illustrate how the use of de facto standard genetic analysis tools enables labs to commit more bioinformatics resources to more challenging and less well-understood pipeline development tasks.

“Genetic analysis is a rapidly changing field, but certain tools are emerging as best practices because they have been used in a wide range of studies and in large-scale efforts such as The Cancer Genome Atlas and the International Cancer Genome Consortium,” Mazzarella said. “Running pipelines based on these validated tools conserves development effort for those analysis tasks that require truly innovative approaches and more extensive evaluation.”

Appistry, a sponsor of the conference, will also exhibit its software solutions geared toward helping clinical labs take their next-generation sequencing (NGS) pipelines into production. As an exhibitor at booth number 7, Appistry will share with conference attendees the challenges of implementing NGS sequencing in clinical labs in the context of its computing environment, Ayrris™. The technology applies computing capabilities developed for the analysis of “big data” in sectors such as finance and defense to the analysis of genetic data and the development of next-generation medicine.

The Clinical Genomics for Cancer Diagnostics Conference will examine novel diagnostic tools and techniques, evaluate their benefit to patient outcome, and focus on steps to implementation. The two-day event will gather leaders in cancer genomics, bioinformatics, clinical genomics, pharmacogenomics, diagnostics, internal medicine, molecular biology, and translational research.

Following the conference, Appistry will also host a webinar featuring the latest pipeline and tools for cancer genetic analysis from the Broad Institute. The one-hour webinar titled “Which Mutations Matter: Analyzing and Annotating Cancer Genomes,” will take place on Oct. 3, 2013 at 12 p.m. EDT. For more information and to register for the free event, please visit appistry.com/webinar.

About Appistry
Appistry (http://www.appistry.com) orchestrates solutions to big data problems and since 2001, Appistry’s fabric technology has empowered organizations and researchers to transform vast data into actionable intelligence. Appistry leverages its fabric computing technology to power Ayrris™, a big-data environment that weaves together high performance computing and analytics to provide the throughput and scale required for diverse applications—from discovering new medical therapies to delivering overnight packages, gaining clarity from financial transactions, or deciphering military satellite images. Appistry is the authorized distributor of the GATK and select genetic analysis tools from the Broad Institute for use in for-profit settings. For the latest Appistry news, visits us on Facebook, Twitter and LinkedIn.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11148047.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
5. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
6. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
7. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
8. Codexis Names Wes Bolsen VP and Chief Marketing Officer
9. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
10. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
11. GenVec President and Chief Executive Officer Announces Retirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... MA (PRWEB) , ... June 23, 2016 , ... ... Peel Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute ... platform of microbial tests introduced last year,” stated Bob Salter, Vice President of ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published ... how a patient who developed lymphedema after being treated for breast cancer benefitted from ... the paradigm for dealing with this debilitating, frequent side effect of cancer treatment. ...
(Date:6/23/2016)... , June 23, 2016 ... Hematology Review, 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 ... , the peer-reviewed journal from touchONCOLOGY, Andrew ... escalating cost of cancer care is placing an ... result of expensive biologic therapies. With the patents ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):